| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.23 | 0.0001 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.0001 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.16 | 0.0001 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.24 | 0.0002 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0004 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0005 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0007 |